@article{ref1,
title="Return to play and re-injury rates in NCAA Division I football players following anterior cruciate ligament reconstruction using hamstring autograft",
journal="Arthroscopy",
year="2021",
author="Jeffers, Kirk W. and Shah, Sagar A. and Calvert, Derek D. and Lemoine, Nathan P. and Marucci, Jack and Mullenix, Shelly and Zura, Robert D. and Bankston, Brent and Bankston, Larry S.",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="PURPOSE: The purpose of this study was to examine the outcomes of ACL reconstruction using quadrupled hamstring (QH) autograft in a cohort of National Collegiate Athletic Association (NCAA) Division I football players. <br><br>METHODS: A retrospective analysis was performed on NCAA Division I football players at a single institution who had transtibial ACL reconstruction using QH autograft from 2001 to 2016. Primary outcomes were ACL re-injury and return to play (RTP). Secondary outcomes were position, percent eligibility used after surgery, graft diameter, Tegner Lysholm scores, concomitant injuries/surgeries, and post-collegiate professional play. <br><br>RESULTS: Thirty-four players had QH autograft ACL reconstruction from 2001-2016. 29 players achieved RTP. Two (6.9%) of the 29 sustained ACL re-injuries. The average RTP was 318 days (range 115-628) after surgery. Players used 79.5% of their remaining collegiate eligibility after surgery. Nine players sustained multi-ligamentous knee injuries. This did not have a significant effect on RTP (p=0.709. mean 306±24 days for isolated ACL, mean of 353±51 for 2 ligaments, mean of 324±114 for 3+ ligaments) and none sustained re-injury. Twenty-eight sustained associated meniscal injury and 8 sustained chondral injuries. The mean post-operative Tegner-Lysholm score was 90.7 out of 100 with mean follow-up of 102 months. Eighteen of these players went on to play professionally, with 17 joining National Football League (NFL) rosters and one an arena team roster. <br><br>CONCLUSION: QH demonstrated an ACL re-injury rate and RTP similar to previously published predominantly BTB ACL re-injury data in elite athletes. This study demonstrates that QH autograft may be a viable option in elite athletes. LEVEL OF EVIDENCE: IV - Case Series.<p /> <p>Language: en</p>",
language="en",
issn="0749-8063",
doi="10.1016/j.arthro.2021.04.057",
url="http://dx.doi.org/10.1016/j.arthro.2021.04.057"
}